Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Phase 2 Study of Talimogene Laherparepvec in Patients With Cutaneous Squamous Cell Cancer

NCT03714828 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT03714828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03714828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Phase 2 Study of Talimogene Laherparepvec in Patients With Cutaneous Squamous Cell Cancer
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Completed
Start date
December 20, 2018
Completion date
July 19, 2023
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous tumor, keratoacanthoma, lesion skin, skin cancer, skin cancer, squamous cell, squamous cell carcinoma